SPAC Market Review – December 2022

by | Jan 3, 2023

What a year for SPACs in 2022. Coming off of a an almost euphoric two years, 2022 brought a gigantic thud to the once hot market. To be fair, SPACs were not alone as the broader equity market also suffered. However the swift change in sentiment in SPACs was nothing short of remarkable as issuance plummeted, quality deals nowhere to be found, and deSPAC performance atrocious.

We take a look at where things stand and recap the last month of 2022 below. But first some quick numbers:

  • There remains 384 SPACs alive and searching for a merger target
  • 151 SPACs are in the process of attempting to close official DAs
  • 12 SPACs have officially filed for extensions

SPAC Liquidations and Excise Tax Clarity

A record number of SPAC liquidations came in swiftly in December with 75 SPACs calling it quits. Many of the liquidations were made EARLY by SPACs to avoid some uncertainty regarding the 1% Excise Tax set to come in 2023.

However, did sponsors make an oopsies? In late December the treasury issued guidance on the proposed rules. The initial guidance appears to exempt pure SPAC liquidations from the tax, meaning that several sponsors likely rushed too quickly to liquidate. Now, many of these sponsors likely would have liquidated regardless, but lost a little extra money on the process of the early liquidations. There are still several uncertainties and Davis Polk provides a good rundown.

The 75 in December alone are more liquidations than the entire history of the SPAC market.

The Great SPAC Maturity Wall

When we first starting talking about the “SPAC Maturity Wall” of early 2023 there were about 270 SPACs that were set to come due in the first three months of 2023. What has transpired has been extraordinary – that 270 number now stands at ~180 with a reduction of about 90 SPACs. The reduction is mostly a result of early liquidations and extensions.

SPAC Maturity Wall as of September 2022

How the Maturity Wall Stands Now

What you’ll notice is that while a lot of the carnage has already been spoken for, there are still a ton of SPACs that will need to wrap up shop or somehow find a way to close a deal. We are looking at billions more of SPAC capital returned to shareholders in Q1.

SPAC Merger Activity

December saw 21 new DAs announced, which is relatively in line with other recent months. While PIPE financing is largely still dead there were a handful of deals that were able to secure some financing.

December announced DAs inline with recent months

SPAC Redemptions Remain Sky High

Clocking in at a staggering 97%, SPAC redemptions on merger votes remains elevated at levels that ensure little of the initially raised capital remains with the deSPAC. The deals that are able to make it across the finish line often have waived minimum cash conditions and very little capital going to the targets.

SPAC IPOs – Swift Drop Off

2020 and 2021 were of course banner years for the SPAC market, with record issuance crushing previous records and average levels. 2022 saw a swift fall from that grace with issuance levels effectively falling off a cliff.

After a record 2021, 2022 new issuance levels fell off a cliff

By the numbers:

  • Total IPOs fell from 614 in 2021 to just 84 in 2022
  • Total capital raised dropped from nearly $163B in 2021 to just over $13B this year. That also equates to an average deal size of ~$150M this year vs. ~$265M in 2021. Deals were fewer AND smaller

DeSPACs – Scarlet Letter

While broader equities have had a rough year, DeSPACs take the cake for many of the worst performers. Of the > 100 SPACs that completed transactions in the last 12 months just 10 are trading at $10 or higher.

Checking in on Serial Sponsors

Just a few sponsors remain in the green on their overall SPAC return record given some of the carnage. We’ve also seen liquidations from some of the premiere sponsors including Gores and FinTech Masala.

What’s Next?

Without a clear catalyst for a return to “normalcy” look for more of the same in SPAC land in Q1 2023. The SPAC market is in bad need of a cleanse, a big a reset to get back to a more balanced level of activity and supply. Once the maturity glut of Q1 passes, don’t be surprised to see some more seasoned SPAC sponsors dipping their toes back into the market.

Until then, here ‘s what you can look for in the near term:

Recent Analysis

Daily SPAC Update – June 13, 2024

Catcha Investment (CHAA) + Crown LNG Approved. DHAC + VSee Labs Deal Approved. SEDA Investor Deck. Feutune Light (FLFV) Updates Trust & Redemptions.

Daily SPAC Update – June 10, 2024

Bayview Acquisition Corp + Oabay Inc. SPAC deal announced. EVE extension vote today. BUJA sets extension vote. PWUP amends merger agreement. COOL postpones to June 26.

Activism Update – June 7

Wisdom Tree (WT) gets Glass Lewis, ISS, and Egon-Jones support. Medallion (MFIN) calls ZimCal self-serving. F9 Investments continues to hammer LL Flooring (LL).

Subscribe to Boardroom Alpha Newsletters

Subscribe to Boardroom Alpha's research to receive the latest on governance, SPACs, and people.


The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.